PCSK9抑制剂在缺血性脑卒中的研究进展
Research advances in PCSK9 inhibitors in ischemic stroke
周正交 1周芝文2
作者信息
- 1. 湖南师范大学临床医学院,湖南 长沙 410013
- 2. 湖南省人民医院(湖南师范大学附属第一医院),湖南 长沙 410013
- 折叠
摘要
PCSK9抑制剂是一种新型的降低低密度脂蛋白胆固醇的药物.近年来,PCSK9抑制剂在缺血性脑卒中的治疗中具有一定的潜力.然而,在缺血性脑卒中方面的研究仍然处于初始阶段,需要进一步的研究以证实PCSK9抑制剂的安全性及有效性.本文总结了近几年PCSK9抑制剂在缺血性脑卒中的作用机制,分析其应用前景.
Abstract
PCSK9 inhibitors are a new type of drug used to reduce the level of low-density lipoprotein cholesterol.In recent years,PCSK9 inhibitors have exhibited certain potential in the treatment of ischemic stroke;however,the research in ischemic stroke is still in its early stages,and further studies are needed to confirm the safety and efficacy of PCSK9 in-hibitors.This article summarizes the mechanism of action of PCSK9 inhibitors in ischemic stroke in recent years and ana-lyzes their potential for future application.
关键词
PCSK9/PCSK9抑制剂/缺血性脑卒中/动脉粥样硬化Key words
PCSK9/PCSK9 inhibitor/Ischemic stroke/Atherosclerosis引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据